Related references
Note: Only part of the references are listed.Cancer Statistics, 2014
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2014)
MicroRNA-451 regulates AMPK/mTORC1 signaling and fascin1 expression in HT-29 colorectal cancer
Min-Bin Chen et al.
CELLULAR SIGNALLING (2014)
KRAS mutation testing of tumours in adults with metastatic colorectal cancer: a systematic review and cost-effectiveness analysis
Marie Westwood et al.
HEALTH TECHNOLOGY ASSESSMENT (2014)
NF-κB in colorectal cancer
Aristeidis G. Vaiopoulos et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2013)
Inhibition of transforming growth factor-β-activated kinase-1 blocks cancer cell adhesion, invasion, and metastasis
D. M. Ray et al.
BRITISH JOURNAL OF CANCER (2012)
TAK1 Inhibition Promotes Apoptosis in KRAS-Dependent Colon Cancers
Anurag Singh et al.
CELL (2012)
Prognostic and Predictive Roles of KRAS Mutation in Colorectal Cancer
Amanda K. Arrington et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
Targeting of TAK1 in inflammatory disorders and cancer
Hiroaki Sakurai
TRENDS IN PHARMACOLOGICAL SCIENCES (2012)
RNAi Screening Identifies TAK1 as a Potential Target for the Enhanced Efficacy of Topoisomerase Inhibitors
S. E. Martin et al.
CURRENT CANCER DRUG TARGETS (2011)
Modulation of Pancreatic Cancer Chemoresistance by Inhibition of TAK1
Davide Melisi et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
KRAS Mutation in Colon Cancer: A Marker of Resistance to EGFR-I Therapy
Ahmad D. Siddiqui et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
KRAS Mutation Screening in Colorectal Cancer: From Paper to Practice
Marwan M. Fakih
CLINICAL COLORECTAL CANCER (2010)
Deregulation of the PI3K and KRAS signaling pathways in human cancer cells determines their response to everolimus
Federica Di Nicolantonio et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Influence of Inflammation-Based Prognostic Score on Mortality of Patients Undergoing Chemotherapy for Far Advanced or Recurrent Unresectable Colorectal Cancer
Mitsuru Ishizuka et al.
ANNALS OF SURGERY (2009)
NF-kappa B Signaling Pathway, Inflammation and Colorectal Cancer
Soly Wang et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2009)
Inflammation and colorectal cancer
Sarah Kraus et al.
CURRENT OPINION IN PHARMACOLOGY (2009)
The Role of Inflammation in the Pathogenesis of Colorectal Cancer
Beth B. McConnell et al.
CURRENT COLORECTAL CANCER REPORTS (2009)
Inflammation and cancer - IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation
SH Itzkowitz et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2004)
Multicenter phase II study of the oral MEK inhibitor, CI-1040, in patients with advanced non-small-cell lung, breast, colon, and pancreatic cancer
J Rinehart et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
NF-κB regulation in the immune system
QT Li et al.
NATURE REVIEWS IMMUNOLOGY (2002)
Linking colorectal cancer to Wnt signaling
M Bienz et al.
CELL (2000)
Share Paper
